(Q37346057)

19 August 2017

1 reference

title

Autoimmune hepatitis. Part B: diagnosis (English)

1 reference

19 August 2017

0 references

Albert J Czaja

1

1 reference

19 August 2017

1 October 2007

1 reference

Expert Review of Gastroenterology & Hepatology

19 August 2017

1 reference

19 August 2017

1

1 reference

19 August 2017

1

1 reference

19 August 2017

129-143

1 reference

Treatment challenges and investigational opportunities in autoimmune hepatitis

19 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Diagnosis and treatment of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Autoimmune hepatitis with incidental histologic features of bile duct injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Ribavirin for syncytial giant cell hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Treatment strategies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Long-term follow-up of chronic active hepatitis of moderate severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Autoimmune hepatitis in childhood: a 20-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Autoimmune hepatitis in African Americans: presenting features and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

An unusual form of autoimmune hepatitis in young Somalian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

High Rate of Positive Anti-Tissue Transglutaminase Antibodies in Chronic Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Supramolecular complexes mediate selenocysteine incorporation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Biosynthesis of selenocysteine on its tRNA in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Variant syndromes of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Immunologic features and HLA associations in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Histological findings in chronic hepatitis C with autoimmune features

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Celiac disease in autoimmune cholestatic liver disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

A case of syncytial giant cell hepatitis with features of a paramyxoviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Autoimmune hepatitis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.129

21 January 2018

Identifiers

DOI

10.1586/17474124.1.1.129

1 reference

19 August 2017

1 reference

PubMed ID

19072441